PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
13-Feb-2024 Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2023 Results Businesswire
13-Feb-2024 VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence Businesswire
13-Feb-2024 Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M Businesswire
13-Feb-2024 OliX Pharmaceuticals Commences Patient Dosing in Phase 1 Clinical Trial of OLX75016 for MASH Businesswire
13-Feb-2024 eGenesis and PorMedTec Announce Successful Production of Genetically Engineered Porcine Donors in Japan Businesswire
13-Feb-2024 Amneal to Participate at Upcoming Investor Conference Businesswire
13-Feb-2024 Areteia Therapeutics Announces Additional $75MM in Series A Financing for Oral Dexpramipexole in Eosinophilic Asthma Businesswire
13-Feb-2024 Rocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADI™ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) Businesswire
13-Feb-2024 Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations Businesswire
13-Feb-2024 Satellos Announces Promising Preliminary Data in Facioscapulohumeral Muscular Dystrophy Businesswire
13-Feb-2024 KalVista Pharmaceuticals Reports Phase 3 KONFIDENT Trial Meets All Endpoints for Sebetralstat as First Oral On-demand Therapy for Hereditary Angioedema Businesswire
13-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
13-Feb-2024 Citryll Announces the Appointment of Maarten Kraan as Chief Medical Officer Businesswire
13-Feb-2024 ACG Becomes the World’s First Capsule Manufacturing Factory to Join the Global Lighthouse Network Community 2023-24 Global Lighthouse Network
13-Feb-2024 Practical Two Day FDA Inspection Online Seminar - ResearchAndMarkets.com Businesswire
13-Feb-2024 European Commission Approves First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia Businesswire
13-Feb-2024 L&T Technology Services and BlackBerry Collaborate to Offer Suite of Automotive Technologies for SDVs Businesswire
13-Feb-2024 Otsuka Announces Phase 3 Topline Results of AVP-786 in the Treatment of Agitation Associated With Dementia Due to Alzheimer’s Disease Businesswire
13-Feb-2024 Oragenics, Inc. Announces Leadership Transition Businesswire
13-Feb-2024 Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Results Businesswire